Saba Capital Management »

Psyence Biomedical shares owned by Saba Capital Management

Quarter-by-quarter ownership of Psyence Biomedical (PBMWW) shares owned by Saba Capital Management from 13F filings

Historical chart of Saba Capital Management investment in Psyence Biomedical

Tip: Access up to 7 years of quarterly data

All positions including Psyence Biomedical held by Saba Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Psyence Biomedical by Saba Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.4k 298k 0.01
2024-03-31 $21k 298k 0.07

More positions owned by Saba Capital Management

Ishares Tr Russell 2000 Etf Call Option (IWM)
Blackrock Esg Cap Allc Term Shs Ben Int (ECAT)
Blackrock Innovation And Grw Shs Ben Int (BIGZ)
Blackrock Health Sciences Te Com Shs (BMEZ)
Blackrock Capital Allocation Trust (BCAT)
Adams Express Company (ADX)
Pimco Dynamic Income Strateg Com Shs Ben Int (PDX)
Blackrock Science & Technolo Shs Ben Int (BSTZ)
Nuveen CA Dividend Advantage Muni. Fund (NAC)
Gabelli Dividend & Income Trust (GDV)
Mainstay Cbre Global (MEGI)
Nuveen Nj Div Advantage Mun (NXJ)
Neuberger Berman Next Genera Common Stock (NBXG)
American Airls Put Option (AAL)
Invesco Van Kampen Muni Opp Trust (VMO)

View all positions for Saba Capital Management

Top funds holding Psyence Biomedical

Cowen And Company
Polar Securities
MMCAP International Inc. SPC
Calamos Advisors
Cantor Fitzgerald, L. P.
Saba Capital Management
Clear Street Derivatives
Aristeia Capital
Context Capital Management
Periscope Capital
Goldman Sachs Group
LMR Partners
Clear Street
D. E. Shaw & Co
Tenor Capital Management

View all funds holding Psyence Biomedical